Published on 12 May 2024 on Zacks via Yahoo Finance
Spruce Biosciences, Inc. (SPRB) Reports Q1 Loss, Tops Revenue Estimates
Spruce Biosciences, Inc. (SPRB) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.32. This compares to loss of $0.40 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 12.50%. A quarter ago, it was expected that this company would post a loss of $0.41 per share when it actually produced a loss of $0.23, delivering a surprise of 43.90%.